Macrophage metabolism in nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype nonalcoholic steatohepatitis (NASH), have emerged as significant contributors to hepatic morbidity worldwide. The pathophysiology of NAFLD/NASH is multifaceted, variable, and remains incompletely understood....

Full description

Bibliographic Details
Main Authors: Wenhui Zhang, Ren Lang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1257596/full
_version_ 1827800030517395456
author Wenhui Zhang
Ren Lang
author_facet Wenhui Zhang
Ren Lang
author_sort Wenhui Zhang
collection DOAJ
description Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype nonalcoholic steatohepatitis (NASH), have emerged as significant contributors to hepatic morbidity worldwide. The pathophysiology of NAFLD/NASH is multifaceted, variable, and remains incompletely understood. The pivotal role of liver-resident and recruited macrophages in the pathogenesis of NAFLD and NASH is widely acknowledged as a crucial factor in innate immunity. The remarkable plasticity of macrophages enables them to assume diverse activation and polarization states, dictated by their immunometabolism microenvironment and functional requirements. Recent studies in the field of immunometabolism have elucidated that alterations in the metabolic profile of macrophages can profoundly influence their activation state and functionality, thereby influencing various pathological processes. This review primarily focuses on elucidating the polarization and activation states of macrophages, highlighting the correlation between their metabolic characteristics and the transition from pro-inflammatory to anti-inflammatory phenotypes. Additionally, we explore the potential of targeting macrophage metabolism as a promising therapeutic approach for the management of NAFLD/NASH.
first_indexed 2024-03-11T20:00:42Z
format Article
id doaj.art-b5bdfd9dba2a4b5da316771cf05abf11
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-11T20:00:42Z
publishDate 2023-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-b5bdfd9dba2a4b5da316771cf05abf112023-10-04T08:50:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-10-011410.3389/fimmu.2023.12575961257596Macrophage metabolism in nonalcoholic fatty liver diseaseWenhui ZhangRen LangNonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype nonalcoholic steatohepatitis (NASH), have emerged as significant contributors to hepatic morbidity worldwide. The pathophysiology of NAFLD/NASH is multifaceted, variable, and remains incompletely understood. The pivotal role of liver-resident and recruited macrophages in the pathogenesis of NAFLD and NASH is widely acknowledged as a crucial factor in innate immunity. The remarkable plasticity of macrophages enables them to assume diverse activation and polarization states, dictated by their immunometabolism microenvironment and functional requirements. Recent studies in the field of immunometabolism have elucidated that alterations in the metabolic profile of macrophages can profoundly influence their activation state and functionality, thereby influencing various pathological processes. This review primarily focuses on elucidating the polarization and activation states of macrophages, highlighting the correlation between their metabolic characteristics and the transition from pro-inflammatory to anti-inflammatory phenotypes. Additionally, we explore the potential of targeting macrophage metabolism as a promising therapeutic approach for the management of NAFLD/NASH.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1257596/fullnonalcoholic fatty liver diseasemacrophageimmunometabolismpolarizationactivationtherapeutic target
spellingShingle Wenhui Zhang
Ren Lang
Macrophage metabolism in nonalcoholic fatty liver disease
Frontiers in Immunology
nonalcoholic fatty liver disease
macrophage
immunometabolism
polarization
activation
therapeutic target
title Macrophage metabolism in nonalcoholic fatty liver disease
title_full Macrophage metabolism in nonalcoholic fatty liver disease
title_fullStr Macrophage metabolism in nonalcoholic fatty liver disease
title_full_unstemmed Macrophage metabolism in nonalcoholic fatty liver disease
title_short Macrophage metabolism in nonalcoholic fatty liver disease
title_sort macrophage metabolism in nonalcoholic fatty liver disease
topic nonalcoholic fatty liver disease
macrophage
immunometabolism
polarization
activation
therapeutic target
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1257596/full
work_keys_str_mv AT wenhuizhang macrophagemetabolisminnonalcoholicfattyliverdisease
AT renlang macrophagemetabolisminnonalcoholicfattyliverdisease